Lumigan Solution/ Drops
Product Images NDC 0023-3205

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lumigan (NDC 0023-3205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lumigan 01 01

FDA Label Image

Lumigan 01 02

FDA Label Image

Lumigan 01 03

Lumigan 01 03
Ilumigan is a brand of bimatoprost ophthalmic solution used to treat eye conditions. It contains 0.01% bimatoprost and is patented by Allergan. The active ingredient is 0.1mg/mL, preserved with benzalkonium chloride 0.2mg/mL. The solution may also contain sodium phosphate, dibasic, citric acid, and purified water. It is recommended to be used once daily at night by applying one drop in the affected eye. The solution should be stored between 2°C-25°C. The bottle has a capacity of 10 ml.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.